LANGERHANS CELL HISTIOCYTOSIS
Clinical trials for LANGERHANS CELL HISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new LANGERHANS CELL HISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for LANGERHANS CELL HISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemo drug tested for rare immune disorder that Won't go away
Disease control OngoingThis study is testing whether a chemotherapy drug called clofarabine can help control Langerhans cell histiocytosis (LCH) and related disorders when they have come back or not responded to previous treatments. It is enrolling 25 participants of all ages who have active disease an…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hope for kids with tough cancers: treatment guided by tumor genetics
Disease control OngoingThis study is testing a personalized approach for children and young adults with advanced cancers that have come back or stopped responding to standard treatments. Doctors first test the genetic makeup of a patient's tumor to look for specific changes. If a matching change is fou…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC